TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Pamela L Kunz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.